Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Psychiatry
•
Community Psychiatry
•
General Psychiatry
Is there a benefit to augmenting treatment for schizophrenia by adding aripiprazole (a partial D2 agonist) to a full D2 antagonist such as haloperidol?
Related Questions
When do you choose to switch to antidepressants vs augmentation in treatment-resistant depression?
How do you approach treatment-refractory schizophrenia which has not responded to multiple antipsychotic trials including clozapine?
When do you consider using multiple antipsychotic medications for chronic management of psychosis?
What are the most effective strategies for managing weight gain associated with antipsychotic medications?
How do you approach the use of SSRIs to treat bipolar depression?
How do you approach a treatment relationship with a patient who is non-adherent to recommendations and also is not interested in transfer to another practitioner?
When do you use seizure prophylaxis in patients on clozapine?
Is there evidence to suggest there is a withdrawal syndrome from muscle relaxants such as tizanidine?
How do you approach psychotropic (demonstrated SSRIs and antipsychotics) induced urinary retention when a patient is otherwise having good response to treatment?
Would you consider over-the-counter dextromethorphan (low dose, slow titration) as augmentation in MDD?
